Latest News about ABBV
Recent news which mentions ABBV
Spotlight on AbbVie: Analyzing the Surge in Options Activity
November 29, 2024
Tickers
ABBV
From Benzinga
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
November 26, 2024
From Benzinga
The Stock Market Is Soaring but These 2 Stocks Are Still Dirt Cheap Buys
November 23, 2024
From Motley Fool
3 Dividend Stocks That Are Screaming Buys in November
November 23, 2024
From Motley Fool
This Elastic Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
November 22, 2024
From Benzinga
Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
November 18, 2024
Tickers
ABBV
From Motley Fool
Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
November 17, 2024
From Benzinga
AbbVie, Bitcoin And An Energy Stock On CNBC's 'Final Trades'
November 15, 2024
From Benzinga
Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock
November 15, 2024
Tickers
ABBV
From Motley Fool
Viking Fund Management Sells Big Oil Stocks In Q3, Cuts Tesla Position In Half, Adds To Largest Position Broadcom
November 14, 2024
From Benzinga
2 Dividend Stocks to Buy Hand Over Fist in November
November 14, 2024
From Motley Fool
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
November 12, 2024
From Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
November 12, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 11, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.